Priftin® is a prescription medicine for the treatment of latent tuberculosis infection (LTBI) in patients two years of age and older at high risk of progression to tuberculosis (TB) disease.
Reference: Priftin Hong Kong Prescribing Information.
Renvela (sevelamer carbonate)
Renvela® (sevelamer carbonate) is an oral phosphate binder used by chronic kidney disease (CKD) adult patients both on dialysis or not on dialysis to treat a condition called hyperphosphatemia, or elevated phosphorus levels, which is associated with heart and bone disease.
Renvela® is a second generation, buffered phosphate binder in tablet format.
Reference: Renvela Hong Kong Prescribing Information